VEGFA and dementia: Among elderly persons, a total of 4,758 (59.9% of all anti-VEGF related reports) ICSRs were identified, eight (0.2%) concerning the SMQ “Dementia” and nine (0.2%) ICSRs for the SMQ “Parkinson-like events.” When restricting disproportionality analysis to persons aged 65 and over, no disproportionality was seen for any of the drug-event pairs at the level of SMQ (Table 3).